| Research Topics: |
| INDEX |
| MCS 2 |
| PRIME 22 |
| aging 14 |
| body 1 |
| brain 11 |
| brainwave 1 |
| cancer 6 |
| climate 3 |
| cognition 4 |
| computers 1 |
| crime 1 |
| dental 1 |
| diabetes 3 |
| drugs 5 |
| economy 1 |
| energy 1 |
| exercise 1 |
| eyes 1 |
| genetics 4 |
| gut 2 |
| heart 4 |
| herbs 1 |
| immune 4 |
| language 1 |
| metabolism 2 |
| microbiome 2 |
| nutrition 14 |
| obesity 1 |
| pain 1 |
| politics 2 |
| psychology 5 |
| quantum 1 |
| reproduction 1 |
| sleep 2 |
| tech 1 |
| unk |
| vaccine 2 |
| virus 1 |
| war-confl |
|
Scanned: 2763 Evaluated: 216 Selected: 48 |
| AGING COGNITION DIABETES | ||||||||
Mdb34-002 | Glucagon-like peptide-1 receptor agonist initiation and risk of clinically recorded Alzheimers disease-type dementia in older adults with type 2 diabetes: a target trial emulation using causal machine learning | |||||||
| Quote: | Interpretation GLP-1 receptor agonists may delay clinically recorded AD-type dementia compared with SU. Comparative effectiveness versus SGLT2 inhibitors may vary, supporting further study. Given the hypothesis-generating nature of these findings, diabetes treatment selection should remain guided by glycemic, cardiovascular, renal, and patient-centered considerations. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.08.21.26361012v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.08.21.26361012v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Jonas Schroeder Octavia-Andreea Ciora Philip Heesen Martin Bendszus Johannes Levin Robert Perneczky Lia Bally Stefan Feuerriegel, | |||||||
| PRIME DIABETES DRUGS METABOLISM OBESITY | ||||||||
Sd341-015 | Experimental Compound Helps Burn Fat Without Muscle Loss | |||||||
| Quote: | In a study published August 21 in Science Advances, the team reports that a molecular compound called 5-tetradecyloxy-2-furoic acid (TOFA) can interfere with the production of lipids such as cholesterol and triglycerides. At the same time, it activates genes that encourage cells to use fat for fuel and produce more energy. In experiments with mice, TOFA improved insulin sensitivity and glucose control, reduced triglyceride levels, and improved signs of fatty liver disease. Obese mice treated with the compound lost fat while showing no significant reduction in lean muscle mass. | |||||||
| Article: | https://www.sciencedaily.com//releases/2026/08/260823014953.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| PRIME DIABETES NUTRITION | ||||||||
Sd343-006 | Turmeric Compound May Protect Blood Vessels from Diabetes Damage | |||||||
| Quote: | Curcumin, the natural compound responsible for turmerics vivid yellow color, is widely studied for its anti-inflammatory and antioxidant properties. New research in rats suggests it may also help protect blood vessels from damage linked to diabetes. | |||||||
| Article: | https://www.sciencedaily.com//releases/2026/08/260824065543.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
|
Javilk's Research Links Newsletter for Week 34 Updated 08/29/2026-12:26:24 AM What interests you? What have you found? Tell me! Drop me a note at Javilk.com to subscribe or submit something. |